Avantogen funds to run out in early November

By Lisa Kerner

Charlotte, N.C., Oct. 17 - Avantogen Ltd. only has $200,000 to fund its operations through early November, according to a news release.

Directors of the Brisbane, Australia, biotechnology company are seeking funding of $200,000 to extend operations beyond November.

Avantogen said it has already implemented cost-saving measures and attributes its cash burn rate to increased auditor compliance costs.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.